Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis

Regner-Nelke L, Pawlitzki M, Willison A, Rolfes L, Oezalp SH, Nelke C, Kölsche T, Korsen M, Grothe M, Groppa S, Luessi F, Engel S, Nelles G, Bonmann E, Roick H, Friedrich A, Knorn P, Landefeld H, Biro Z, Ernst M, Bayas A, Menacher M, Akgün K, Kleinschnitz C, Ruck T, Ziemssen T, Pul R, Meuth SG.

Neurol Res Pract. 2022 Nov 7;4(1):55.

https://doi.org/10.1186/s42466-022-00219-3

Multiple SkleroseMS Behandlung